What's breaking now, across thousands of outlets.
(MedPage Today) -- The regulatory status of a low-dose atropine eye drop formulation for myopia remained unresolved following a day-long FDA advisory committee meeting, but closing comments did not bode well for SYD-101. The Dermatologic and Ophthalmic...
We haven't written up this one. MedPage Today has the full story — the link below goes straight to it.
Learn why certain “unhealthy” diets seemed to boost cancer immunotherapy in mice and how it’s related to the gut microbiome.
A psychologist explains in a Cleveland Clinic guide how burnout shows up in body and mood, how it differs from depression, and how to recover.
Trace the history of Social Security through 10 turning points, from Roosevelt's 1935 law and the first checks to Medicare, the 1983 reforms and today's trust fund outlook
After a whirlwind third quarter that saw two FDA approvals but a major setback in Angelman syndrome, Ultragenyx is laying off staff for the second time this year. The California biopharma
Learn how the spread of H5N1 avian influenza among dairy farms in Washington State led to the first human bird flu death in the U.S. in 2026.
